To confirm that CD133 is a marker of tumor initiation in SW480 cells, all three subpopulations were prospectively isolated via FACS based on their CD133 expression, and subcutaneously inoculated in NSG mice to monitor tumor formation. This evidence concerns the gene PROM1 and neoplasm.